Modivcare CEO – Daniel Greenleaf (Age – 60)

Leadership Update: Modivcare

Daniel Greenleaf departed as Modivcare CEO in August 2022. He is now CEO of Duly Health and Care, the largest independent multi-specialty physician group in the nation. L. Heath Sampson succeeded him as CEO and led the company through Chapter 11 bankruptcy proceedings in 2025.

Read about current Modivcare CEO Heath Sampson →

Modivcare Inc. (formerly The Providence Service Corporation) is a technology-enabled healthcare services company that addresses social determinants of health through non-emergency medical transportation (NEMT), personal care, nutritious meal delivery, and remote patient monitoring. Former Modivcare CEO Daniel E. Greenleaf led the company from December 2019 until his departure in August 2022. Under his leadership, Modivcare grew revenue from $1.5 billion to $2.4 billion, expanded EBITDA from $52 million to over $200 million, and completed six transformative acquisitions including CareFinders Total Care and VRI. Greenleaf is now CEO of Duly Health and Care in Downers Grove, Illinois.

Read on to discover former Modivcare CEO email address, Daniel Greenleaf net worth in 2026, salary and compensation history, career timeline, family details, and more.
Daniel Greenleaf former Modivcare CEO
Daniel E. Greenleaf, former President & CEO of Modivcare Inc.

Daniel Greenleaf – Quick Facts

Daniel E. Greenleaf — At a Glance
Full Name Daniel E. Greenleaf
Former Position President & Chief Executive Officer
Company (Former) Modivcare Inc. (formerly NASDAQ: MODV)
Current Role CEO, Duly Health and Care
Age ~60 years (as of 2026)
Education B.A. Economics, Denison University; MBA Health Administration, University of Miami
Net Worth (Est. 2026) $15–20 Million
Total Compensation (FY2021) ~$6–8 Million
Modivcare CEO Tenure December 2019 – August 2022
Military Service Captain & Navigator, U.S. Air Force (Gulf War)
LinkedIn Daniel Greenleaf on LinkedIn

Modivcare Competitors

Modivcare operates in the technology-enabled healthcare services industry, with its core NEMT business facing competition from both traditional healthcare services firms and emerging technology platforms. Key competitors include:

  • MTM (Medical Transportation Management) – major NEMT broker and rival
  • Veyo – technology-driven NEMT platform
  • Southeastrans – regional NEMT provider
  • Lyft Healthcare / Uber Health – rideshare NEMT entrants
  • Amedisys – home health and personal care services
  • Centene Corporation – managed care with NEMT offerings
  • Option Care Health – home and alternate site infusion services

Daniel Greenleaf Net Worth 2026 – Modivcare CEO Salary

As of 2026, Daniel Greenleaf’s net worth is estimated at approximately $15–20 million USD. This figure accounts for his Modivcare stock holdings (approximately 35,078 shares at peak valuation), his $9.55 million departure settlement from Modivcare in May 2023, and his current CEO compensation at Duly Health and Care. Greenleaf’s total compensation while serving as Modivcare CEO was estimated at $6–8 million annually, consisting of base salary, stock awards, and performance bonuses.

Modivcare CEO Compensation Overview (FY2021)

Component Estimated Amount (USD) Share
Base Salary $750,000 ~11%
Annual Bonus $1,200,000 ~18%
Stock Awards & Options $4,500,000 ~67%
Other Compensation $250,000 ~4%
TOTAL (ESTIMATED) ~$6,700,000 100%
Key Insight: After departing Modivcare in August 2022, Daniel Greenleaf received a $9.55 million settlement in May 2023, resolving a dispute over his departure terms and owed compensation. The majority of his CEO compensation at Modivcare was performance-based, tied to stock awards and equity incentives.

Modivcare Net Worth – Is Modivcare Profitable?

Modivcare faced significant financial challenges following Greenleaf’s departure. While the company grew revenue to $2.78 billion in fiscal year 2024, it reported a net loss of $201.3 million. Burdened by over $1.4 billion in debt from acquisitions, Modivcare filed for Chapter 11 bankruptcy in August 2025. The company is restructuring under CEO Heath Sampson, aiming to reduce debt by approximately $1.1 billion (80%) and emerge from bankruptcy by early 2026.

Modivcare Financial Summary

Metric FY2024 FY2023 YoY Change
Revenue $2.78B $2.75B ▲ 1.1%
Net Income (Loss) ($201.3M) ($204.5M) ▲ Improved
Adjusted EBITDA $161.1M $204.4M ▼ 21.2%
EBITDA Margin 5.8% 7.4% ▼ 160 bps
Total Debt ~$1.4B ~$1.5B
Employees ~25,000 ~25,000
Status Chapter 11 Bankruptcy (Aug 2025)
Greenleaf’s Legacy: During Daniel Greenleaf’s tenure (2019–2022), Modivcare grew revenue by 60% from $1.5B to $2.4B and completed six acquisitions, including CareFinders Total Care ($340M) and VRI for remote patient monitoring. However, the debt accumulated from these acquisitions contributed to the company’s later financial challenges.

Modivcare CEO Email | Daniel Greenleaf Contact

Daniel Greenleaf is no longer at Modivcare. His former Modivcare email addresses ([email protected] and [email protected]) are no longer active. He can be reached through his current position at Duly Health and Care.

Contact Information
Former Email (Modivcare) [email protected] (no longer active)
Current Company Duly Health and Care (CEO)
LinkedIn Daniel Greenleaf on LinkedIn
Duly Health HQ 1100 West 31st Street, Downers Grove, IL 60515
Duly Health Website dulyhealthandcare.com

Career & Education – Company, University, & College

Daniel E. Greenleaf has over 25 years of experience in healthcare leadership, with a remarkable track record of transforming underperforming healthcare companies. He is known for operational excellence, strategic acquisitions, and driving growth in complex healthcare environments.

Daniel Greenleaf Career Timeline

Period Role Company
Early 1990s Captain & Navigator U.S. Air Force (Gulf War)
Late 1990s–2000s President & CEO Coram Healthcare / Coram Specialty Services
~2010–2013 CEO & Chairman Home Solutions Infusion Services
2013–2019 President & CEO BioScrip Infusion Services
Dec 2019–Aug 2022 President & CEO Modivcare Inc.
Jun 2023–Present Chief Executive Officer Duly Health and Care

Greenleaf began his professional career in the U.S. Air Force, serving as a captain and navigator during the Gulf War. After military service, he entered healthcare leadership. As President and CEO of Coram Specialty Services, he grew the company into the top-performing home infusion provider in the country, increasing its valuation from $350 million to $2.1 billion prior to its sale to CVS.

He then led the turnaround of Home Solutions Infusion Services as CEO and Chairman, ultimately orchestrating its sale to BioScrip. As President and CEO of BioScrip Inc., he oversaw the largest independent infusion care provider in the nation with 70 locations and approximately $800 million in revenue, spearheading its successful merger with Option Care Health (NASDAQ: BIOS).

In December 2019, Greenleaf was appointed President and CEO of The Providence Service Corporation (later Modivcare). During his tenure, he strategically rebranded the company, grew its workforce from 4,000 to 25,000 employees, completed six acquisitions adding $1.3 billion in value, and positioned Modivcare as the leading technology-enabled provider addressing healthcare inequities. He departed Modivcare in August 2022, and in June 2023 was named CEO of Duly Health and Care, the largest independent multi-specialty physician group in the nation.

Education

University Degree / Program Website
Denison University Bachelor of Arts in Economics denison.edu
University of Miami MBA, Health Administration (Summa Cum Laude) miami.edu

Daniel Greenleaf Wiki – Age, Family, & More

Daniel Greenleaf is approximately 60 years old as of 2026. He has two children: Dana, a graduate of Kenyon College, and Hannah, a graduate of New York University (NYU). His father was a military officer who served for 35 years, and his mother was a teacher who worked with disabled children. The family foundation he started, The Greenleaf Family Foundation, supports philanthropic causes.

Greenleaf is an avid skier and outdoor enthusiast who finds Colorado an ideal place for living. At Denison University, he was an all-conference tight end and team captain on the football team. He emphasizes the importance of being self-aware, ready for uncertainty, and accountable to business, friends, and family as key pillars for redefining success.

Notable Achievements & Recognitions

  • Coram Healthcare Turnaround – Grew Coram valuation from $350M to $2.1B before CVS acquisition
  • BioScrip Transformation – Led largest independent infusion care provider through successful merger with Option Care Health
  • Modivcare Growth – Grew revenue 60% ($1.5B to $2.4B) and EBITDA from $52M to $200M+
  • Six Transformative Acquisitions – Completed $1.3B+ in strategic acquisitions at Modivcare
  • U.S. Air Force Veteran – Served as captain and navigator during the Gulf War
  • Denison University Football – All-conference tight end and team captain
  • Duly Health Expansion – Leading physician group acquisitions and specialty expansion in 2025–2026

About Modivcare

Modivcare Inc. (formerly The Providence Service Corporation) is a technology-enabled healthcare services company headquartered in Denver, Colorado. The company addresses social determinants of health by connecting underserved patient populations with critical healthcare services. Modivcare filed for Chapter 11 bankruptcy in August 2025 and is undergoing restructuring.

Service Segment Description
NEMT (Non-Emergency Medical Transportation) Largest NEMT broker in the U.S.; 24/7 transportation via app, web, phone for Medicaid members
Personal Care Services In-home care ranging from daily living assistance to full-time live-in care
Remote Patient Monitoring Care Everyday platform for vitals monitoring, medication management, emergency response
Nutritious Meals Meal delivery services for patients with limited healthcare access

During Greenleaf’s era, Modivcare traded on NASDAQ under the ticker MODV. The company was delisted from NASDAQ following its Chapter 11 filing in August 2025. At its peak in September 2021, the stock traded at $210.32 per share. The company has approximately 25,000 employees and generated $2.78 billion in revenue in fiscal year 2024.

Frequently Asked Questions (FAQ)

Who is Daniel Greenleaf?

Daniel E. Greenleaf is a seasoned healthcare executive who served as President and CEO of Modivcare Inc. from December 2019 to August 2022. He is currently the CEO of Duly Health and Care, the largest independent multi-specialty physician group in the United States. He brings over 25 years of experience transforming healthcare companies.

Is Daniel Greenleaf still the CEO of Modivcare?

No, Daniel Greenleaf departed as Modivcare CEO in August 2022. He was succeeded by L. Heath Sampson, who currently serves as CEO and is leading the company through Chapter 11 bankruptcy restructuring. Greenleaf joined Duly Health and Care as CEO in June 2023.

What is Daniel Greenleaf’s net worth in 2026?

As of 2026, Daniel Greenleaf’s net worth is estimated at $15–20 million USD, reflecting his Modivcare stock holdings, a $9.55 million departure settlement, and ongoing CEO compensation at Duly Health and Care.

What was Daniel Greenleaf’s salary at Modivcare?

Daniel Greenleaf’s total annual compensation at Modivcare was estimated at $6–8 million, including base salary, performance bonuses, and stock awards. The majority of his compensation was performance-based and tied to equity incentives.

What is Daniel Greenleaf’s email address?

Greenleaf’s former Modivcare email addresses ([email protected] and [email protected]) are no longer active. He can be contacted through his current role at Duly Health and Care or via his LinkedIn profile.

What happened to Modivcare after Greenleaf left?

After Greenleaf’s departure, Modivcare faced mounting financial challenges. The company reported net losses of over $200 million in both 2023 and 2024. Burdened by $1.4 billion in debt from acquisitions, Modivcare filed for Chapter 11 bankruptcy in August 2025 and was delisted from NASDAQ. The company aims to reduce debt by approximately 80% through restructuring.

Article last updated:February 2026March 2, 2026

Disclaimer: All information presented in this article has been compiled from publicly available sources, including SEC filings, official company press releases, and reputable news outlets. This content is provided for informational purposes only and does not constitute financial or investment advice.